Endo Int'l (ENDP) Tops Q3 EPS by 24c; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Endo Reports Third-Quarter 2017 Financial Results
November 9, 2017 4:01 PM ESTDUBLIN, Nov. 9, 2017 /PRNewswire/ --
Third-quarter 2017 revenues of $787 million and reported $0.45 diluted (GAAP) loss per share from continuing operations Third-quarter 2017 adjusted diluted earnings per share (EPS) from continuing operations of $0.91 Third-quarter 2017 Sterile Injectables revenues increased 28 percent to $175 million Third-quarter 2017 Branded Specialty Products revenues increased 11 percent to $114 million Third-quarter 2017 reported (GAAP) consolidated net loss of $97 million Third-quarter 2017 adjusted EBITDA of $375 million Company reaffirms full year 2017 revenues, adjusted diluted EPS and adjusted EBITDA financial guidance provided in August 2017Endo... More
